Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Tobacco Use Disorder
Interventions
DRUG

Varenicline

Participants randomized to receive varenicline will follow the Pfizer recommended dosing schedule (0.5 mg QD on days 1-3, 0.5 mg BID on days 4-7, and 1 mg BID thereafter.

DRUG

Placebo pill

Participants randomized to receive placebo pill will follow the same dosing schedule as those randomized to receive varenicline (1 pill labelled 0.5 mg on days 1-3, pills labelled 0.5 mg BID on days 4-7, and pills labelled 1 mg BID thereafter.

Trial Locations (1)

08901

Division of Addiction Psychiatry, New Brunswick

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Rutgers, The State University of New Jersey

OTHER

NCT01308736 - Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit | Biotech Hunter | Biotech Hunter